| Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 … JA Bogart, XF Wang, GA Masters, J Gao, R Komaki, CS Kuzma, ... Journal of Clinical Oncology 39 (15_suppl), 8505-8505, 2021 | 36 | 2021 |
| Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: exploratory analysis of the REMAGUS02 trial AS Hamy, S Tury, X Wang, J Gao, JY Pierga, S Giacchetti, E Brain, ... Journal of Clinical Oncology 37 (8), 624, 2019 | 36 | 2019 |
| Radiogenomic analysis of locally advanced lung cancer based on CT imaging and intratreatment changes in cell-free DNA KJ Lafata, MN Corradetti, J Gao, CD Jacobs, J Weng, Y Chang, C Wang, ... Radiology: Imaging Cancer 3 (4), e200157, 2021 | 34 | 2021 |
| Utilization of lung cancer screening in the Medicare fee-for-service population TD Tailor, BC Tong, J Gao, LM Henderson, KR Choudhury, GD Rubin Chest 158 (5), 2200-2210, 2020 | 34 | 2020 |
| High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)/RTOG 0538 J Bogart, X Wang, G Masters, J Gao, R Komaki, LE Gaspar, J Heymach, ... Journal of Clinical Oncology 41 (13), 2394-2402, 2023 | 27 | 2023 |
| Characterizing the potency and impact of carbon ion therapy in a primary mouse model of soft tissue sarcoma JM Brownstein, AJ Wisdom, KD Castle, YM Mowery, P Guida, CL Lee, ... Molecular cancer therapeutics 17 (4), 858-868, 2018 | 27 | 2018 |
| A geospatial analysis of factors affecting access to CT facilities: implications for lung cancer screening TD Tailor, BC Tong, J Gao, KR Choudhury, GD Rubin Journal of the American College of Radiology 16 (12), 1663-1668, 2019 | 25 | 2019 |
| Clinical and radiographic predictors of successful therapeutic bronchoscopy for the relief of malignant central airway obstruction CX Giovacchini, ER Kessler, CM Merrick, J Gao, X Wang, MM Wahidi, ... BMC pulmonary medicine 19, 1-10, 2019 | 24 | 2019 |
| AFT-16: Phase II trial of neoadjuvant and adjuvant atezolizumab and chemoradiation (CRT) for stage III non-small cell lung cancer (NSCLC). HJ Ross, DE Kozono, JJ Urbanic, TM Williams, C DuFrane, I Bara, ... Journal of Clinical Oncology 39 (15_suppl), 8513-8513, 2021 | 23 | 2021 |
| The role of reconstructive surgery after skeletal and soft tissue sarcoma resection V Suresh, J Gao, SH Jung, B Brigman, W Eward, D Erdmann Annals of Plastic Surgery 80 (6S), S372-S376, 2018 | 16 | 2018 |
| Characterization of sentinel lymph node immune signatures and implications for risk stratification for adjuvant therapy in melanoma NE Farrow, EK Holl, J Jung, J Gao, SH Jung, RN Al-Rohil, MA Selim, ... Annals of surgical oncology 28, 3501-3510, 2021 | 15 | 2021 |
| Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma GM Beasley, MC Brown, NE Farrow, K Landa, RN Al-Rohil, MA Selim, ... Journal for ImmunoTherapy of Cancer 10 (9), 2022 | 11 | 2022 |
| AFT-16: Phase II trial of atezolizumab before and after definitive chemoradiation (CRT) for unresectable stage III non-small cell lung cancer (NSCLC). HJ Ross, DE Kozono, JJ Urbanic, TM Williams, C Dufrane, I Bara, ... Journal of Clinical Oncology 38 (15_suppl), 9045-9045, 2020 | 11 | 2020 |
| Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance)/RTOG 0538 JA Bogart, X Wang, GA Masters, J Gao, R Komaki, LE Gaspar, ... Lung Cancer 156, 68-71, 2021 | 10 | 2021 |
| Variable learning curve of basic rigid bronchoscopy in trainees K Mahmood, MM Wahidi, RW Shepherd, AC Argento, LB Yarmus, H Lee, ... Respiration 100 (6), 530-537, 2021 | 7 | 2021 |
| Definitive Radiotherapy for Inoperable Stage IIB Non–small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness CD Jacobs, J Gao, X Wang, JM Clarke, B Tong, NE Ready, G Suneja, ... Clinical lung cancer 21 (3), 238-246, 2020 | 6 | 2020 |
| Antibiotic prophylaxis for megaprosthetic reconstructions: drug and dosing may matter more than duration IS Byers, NA Turner, NL Levine, AL Lazarides, DR Evans, I Spasojevic, ... Antimicrobial Agents and Chemotherapy 66 (10), e00140-22, 2022 | 5 | 2022 |
| Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non‐Small Cell Lung Cancer in CALGB 9730 (Alliance A151729) ML Wong, J Gao, G Thanarajasingam, JA Sloan, AC Dueck, PJ Novotny, ... The oncologist 26 (3), e435-e444, 2021 | 5 | 2021 |
| Nomogram predicting overall survival benefit of stereotactic ablative radiotherapy for early-stage non-small cell lung cancer CD Jacobs, K Mehta, J Gao, X Wang, JK Salama, CR Kelsey, JA Torok Clinical Lung Cancer 23 (2), 177-184, 2022 | 4 | 2022 |
| LASSO and Elastic Net Tend to Over-Select Features L Liu, J Gao, G Beasley, SH Jung Mathematics 11 (17), 3738, 2023 | 2 | 2023 |
Chris KelseyProfessor, Duke University Medical CenterVerified email at duke.edu
